Fifteen sexually mature rams, five each of Barki, Awassi (I, imported from Syria) and Awassi (LB, locally born in Egypt) were used in this study. Semen was collected monthly from rams for a period of 12 months to study semen characteristics. In addition, blood samples were collected from rams during the four seasons of the year to determine serum triiodothyronine (T3) and testosterone hormones. Results showed that Barki and Awassi (I and LB) rams are continuous breeders as they show sexual desire and produce semen all the year round. However, monthly variations in semen quality were detected. Relative testes volume, ejaculate volume, sperm concentration, total sperm output, sperm motility, percentage of live sperm and serum testosterone level were higher during summer months than at other months of the year. Serum T3 was significantly higher in winter and spring than that observed in summer and autumn. In addition, percentages of dead spermatozoa were higher in winter and early spring than in autumn and summer. Furthermore, summer months showed moderate percentages of abnormal spermatozoa and spermatozoa without intact acrosomes. These results indicate that ram semen quality in the subtropics may be better during summer months than during other months of the year.
Fifteen sexually mature rams, five each of Barki, Awassi (I, imported from Syria) and Awassi (LB, locally born in Egypt) were used to study the biochemical and enzymatic properties of seminal plasma for 12 months. The biochemical analyses of ram seminal plasma indicated that the highest values of total protein, albumin (A), globulin (G), fructose, total lipids and cholesterol were recorded in late summer and early autumn, while A/G and AST/ALT ratios exhibited the lowest values. Lowest values of the same parameters were recorded in winter and late spring, while ratios of A/G and aspartate amino transferase (AST)/alanine amino transferase (ALT) showed the highest values in spring. AST enzyme activity showed highest activity in winter and summer and lowest activity in autumn, while ALT exhibited the highest activity in winter and the lowest activity in spring. The relationships between these parameters and semen quality are discussed.
Ionizing radiation is one of the environmental factors that may contribute to liver dysfunction through a mechanism involving oxidative stress. This investigation studied the possible therapeutic effects of nano-HAp on hepatotoxicity in rats induced with gamma (γ) radiation. The study was carried out using 3 groups with 10 rats in each. Group 1 comprised the non-irradiated control rats, whereas the rats in groups 2 and 3 received a single dose of 10 Gy γ-radiation. The rats in group 3 were treated with nano-HAp [100 mg·(kg body mass)] once a week for 2 weeks starting the day after irradiation. The results showed that the rats exposed to γ-radiation had fragmented DNA, and significantly decreased levels of liver tissue enzymes such as paraoxonase 1, gamma glutamyl, alanine aminotransferase (ALT), and aspartate aminotransferase (AST). Pro-inflammatory factors such as interleukin (IL)-2, IL-6, tumor necrosis factor alpha (TNF-α), and interferon gamma (IFN-γ) in tissue were significantly increased compared with the controls. Also, exposure to γ-radiation significantly decreased the activity of superoxide dismutase and glutathione oxidase and increased lipid peroxidation in liver tissue. These effects were accompanied by severe histopathological changes to the hepatocytes. Intravenous injection of nano-HAp after irradiation has significant therapeutic potential against irradiation-induced liver damage because the treatment with nano-HAp restored antioxidant activity in the liver, antagonized the significant changes in the levels of IL-2, IL-6, TNF-α, IFN-γ, and restored the tissue level of paraoxonase 1, gamma glutamyl, ALT, and AST. Administering nano-HAp seemed to relieve the pathological changes induced by γ-radiation. Based on these results, it could be concluded that nano-HAp may have a therapeutic effect against liver dysfunction induced by γ-radiation through antagonizing the generation of free radicals and enhancing the antioxidant defense mechanisms.
The present study aimed to investigate the mode of action of nano-CaPs in vivo as a therapy for solid tumor in mice. To achieve this goal, Ehrlich Ascites Carcinoma (EAC) was transplanted into 85 Swiss male albino mice. After nine days, the mice were divided into 9 groups. Groups 1 and 2 were allocated as the EAC control. Groups 3 and 4 were injected once intratumorally (IT) by nano-calcium phosphate (nano-CaP). Groups 5 and 6 received once intraperitoneal injection (IP) of nano-CaP. Groups 7, 8, and 9 received nano-CaP (IP) weekly. Blood samples and thigh skeletal muscle were collected after three weeks from groups 1, 3, 5, and 7 and after four weeks from groups 2, 4, 6, and 8. On the other hand, group 9 received nano-CaP (IP) for four weeks and lasted for three months to follow up the recurrence of tumor and to ensure the safety of muscle by histopathological analysis. Tumor growth was monitored twice a week throughout the experiment. DNA fragmentation of tumor cells was evaluated. In thigh tissue, noradrenaline, dopamine, serotonin (5HT), and gamma-aminobutyric acid (GABA) were measured. In serum, 8-Hydroxy-deoxyguanosine (8-OHDG), adenosine triphosphate (ATP), and vascular endothelial growth factor (VEGF) were analyzed. Histopathological and biochemical results showed a significant therapeutic effect of nano-CaP on implanted solid tumor and this effect was more pronounced in the animals treated IP for four weeks. This improvement was evident from the repair of fragmented DNA, the significant decrease of caspase-3, 8-OHDG, myosin, and VEGF, and the significant increase of neurotransmitters (NA, DA, 5HT, and GABA). Additionally, histopathological examination showed complete recovery of cancer cells in the thigh muscle after three months.
Objective: This study was planned to investigate the possible therapeutic effects of newly synthesis method of nano-silver (nAg) on hepatotoxicity induced by lead nitrate exposure in albino rats.Design and Methods: Rats were designed into three groups. (1) normal control. (2) rats were injected with lead nitrate. (3) rats were injected with lead nitrate followed by nano-silver/hydroxyl apatite (nAg/HAp). The degree of DNA fragmentation was analyzed, in addition to immune status, by measuring the levels of interferon-γ (IFN-γ), tumor necrosis factor-α (TNF-α), and interleukin-2 (IL-2). The activities of superoxide dismutase (SOD) and glutathione peroxidase (GPx) and malondialdehyde (MDA) content as well as liver enzymes were measured. The levels of hepatic heat shock protein-70 (HSP-70), caspase-3, and metalloproteinase-9 were also measured as markers for inflammation and apoptosis. Histopathological examination of liver tissue was performed. Results: The results revealed the potent efficacy of nAg/HAp composite in repairing the fragmented DNA and ameliorating most of the investigated parameters by significant elevation in the levels of hepatic alanine aminotransferase (ALT), SOD, and (GPx) activities. Conversely, there was a significant decrease in hepatic gamma-glutamyl transpeptidase (γ-GT), MDA, IL-2, IFN-γ, TNF-α, matrix MMP-9, HSP-70, and caspase-3 levels upon treatment. Histopathological findings were correlated with biochemical results and confirmed the difference between the lead-intoxicated and nAg-treated groups and achieved by disappearance most of the pathological phenomenon in treated rats. Conclusion:The results illustrated newly synthesis and characterization for nAg preparation carried by nHAp, which provides a biosafe composite with unique chemical and biological properties possess anti-hepatotoxicity effect.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.